Market Overview

DowDuPont Announces Updates to Its Materials Science Division and Specialty Products Division Advisory Committees

Share:

DowDuPont (NYSE:DWDP) today announced that Wesley G. Bush, Chairman and
CEO of Northrop Grumman, will join the Advisory Committee of its
Materials Science Division; and Rajiv L. Gupta, Former Chairman and CEO
of Rohm & Haas Company, will join the Advisory Committee of its
Specialty Products Division.

Jeff Fettig, executive chairman of DowDuPont, said, "The addition of Wes
Bush to the Materials Science Advisory Committee is a well-suited
addition for the division's disciplined, focused and market-oriented
approach. The new Dow's management team will benefit from his experience
driving an industry-leading growth company focused on innovative
strategies centered on customer needs. Wes joins a highly experienced
and well-rounded Advisory Committee focused on delivering near-term
value and long-term growth for our customers and shareholders."

Ed Breen, chief executive officer of DowDuPont, said, "The addition of
Rajiv Gupta to the Specialty Products Advisory Committee further
underscores the great potential of this business and our focus on
optimizing its value. We look forward to benefitting from Raj's
significant operating and governance experience, depth of understanding
of our portfolio and end markets, and track record in value creation. He
joins other recently appointed, highly experienced individuals who are
now part of our Advisory Committees, helping to ensure that each of our
divisions is best positioned to be an industry-leading growth company."

As previously announced, the Materials Science Division (Dow) is
anticipated to separate by the end of the first quarter of 2019, and
Agriculture (Corteva Agriscience) and Specialty Products (DuPont)
Divisions are expected to separate by June 1, 2019.

Biographies of New Members

About Wesley G. Bush

Mr. Bush is Chairman and CEO of Northrop Grumman Corporation, a leader
in global security. He was elected to the company's Board of Directors
in 2009; named CEO and president in January 2010; and assumed the role
of chairman in July 2011. Prior to the acquisition of TRW by Northrop
Grumman, Bush had served since 2001 as president and chief executive
officer for TRW's UK-based global Aeronautical Systems. He joined TRW in
1987 and prior to joining TRW, he held engineering positions with both
the Aerospace Corporation and Comsat Labs. Mr. Bush serves as a director
of Northrop Grumman and Norfolk Southern, and on the boards of several
non-profit organizations including the Inova Health System, Conservation
International, the Business Roundtable, and the USO.

About Rajiv L. Gupta

Mr. Gupta was the Chairman and CEO of Rohm & Haas Company from 1999
until 2009, when it was acquired by Dow Chemical. Prior to that, he held
various other positions at Rohm & Haas, which he joined in 1971. He
currently serves as a director of two publicly traded companies,
Arconic, Inc and Aptiv, PLC, where he is Chairman. He has been a Senior
Advisor to New Mountain Capital, LLC since 2009. He previously served as
Chairman of Delphi Automotive PLC, and as a director of HP Inc., The
Vanguard Group, Inc., and Tyco International plc.

About DowDuPont™

DowDuPont (NYSE:DWDP) is a holding company comprised of The Dow
Chemical Company and DuPont with the intent to form strong, independent,
publicly traded companies in agriculture, materials science and
specialty products sectors that will lead their respective industries
through productive, science-based innovation to meet the needs of
customers and help solve global challenges. For more information, please
visit us at www.dow-dupont.com.

Cautionary Statement About Forward-Looking Statements

This communication contains "forward-looking statements" within the
meaning of the federal securities laws, including Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. In this context, forward-looking
statements often address expected future business and financial
performance and financial condition, and often contain words such as
"expect," "anticipate," "intend," "plan," "believe," "seek," "see,"
"will," "would," "target," similar expressions, and variations or
negatives of these words.

On December 11, 2015, The Dow Chemical Company ("Dow") and E. I. du Pont
de Nemours and Company ("DuPont") announced entry into an Agreement and
Plan of Merger, as amended on March 31, 2017, (the "Merger Agreement")
under which the companies would combine in an all-stock merger of equals
transaction (the "Merger Transaction"). Effective August 31, 2017, the
Merger Transaction was completed and each of Dow and DuPont became
subsidiaries of DowDuPont Inc. ("DowDuPont"). For more information,
please see each of DowDuPont's, Dow's and DuPont's latest annual,
quarterly and current reports on Forms 10-K, 10-Q and 8-K, as the case
may be, and the joint proxy statement/prospectus included in the
registration statement on Form S-4 filed by DowDuPont with the SEC on
March 1, 2016 (File No. 333-209869), as last amended on June 7, 2016,
and declared effective by the SEC on June 9, 2016 (the "Registration
Statement") in connection with the Merger Transaction.

Forward-looking statements by their nature address matters that are, to
different degrees, uncertain, including the intended separation of
DowDuPont's agriculture, materials science and specialty products
businesses in one or more tax efficient transactions on anticipated
terms (the "Intended Business Separations"). Forward-looking statements
are not guarantees of future performance and are based on certain
assumptions and expectations of future events which may not be realized.
Forward-looking statements also involve risks and uncertainties, many of
which are beyond the company's control. Some of the important factors
that could cause DowDuPont's, Dow's or DuPont's actual results to differ
materially from those projected in any such forward-looking statements
include, but are not limited to: (i) successful integration of the
respective agriculture, materials science and specialty products
businesses of Dow and DuPont, including anticipated tax treatment,
unforeseen liabilities, future capital expenditures, revenues, expenses,
earnings, productivity actions, economic performance, indebtedness,
financial condition, losses, future prospects, business and management
strategies for the management, expansion and growth of the combined
operations; (ii) impact of the divestitures required as a condition to
consummation of the Merger Transaction as well as other conditional
commitments; (iii) achievement of the anticipated synergies by
DowDuPont's agriculture, materials science and specialty products
businesses; (iv) risks associated with the Intended Business
Separations, including those that may result from the comprehensive
portfolio review undertaken by the DowDuPont board, changes and timing,
including a number of conditions which could delay, prevent or otherwise
adversely affect the proposed transactions, including possible issues or
delays in obtaining required regulatory approvals or clearances related
to the Intended Business Separations, disruptions in the financial
markets or other potential barriers; (v) the risk that disruptions from
the Intended Business Separations will harm DowDuPont's business (either
directly or as conducted by and through Dow or DuPont), including
current plans and operations; (vi) the ability to retain and hire key
personnel; (vii) potential adverse reactions or changes to business
relationships resulting from the completion of the merger or the
Intended Business Separations; (viii) uncertainty as to the long-term
value of DowDuPont common stock; (ix) continued availability of capital
and financing and rating agency actions; (x) legislative, regulatory and
economic developments; (xi) potential business uncertainty, including
changes to existing business relationships, during the pendency of the
Intended Business Separations that could affect the company's financial
performance and (xii) unpredictability and severity of catastrophic
events, including, but not limited to, acts of terrorism or outbreak of
war or hostilities, as well as management's response to any of the
aforementioned factors. These risks, as well as other risks associated
with the merger and the Intended Business Separations, are more fully
discussed in (1) the Registration Statement and (2) the current,
quarterly and annual reports filed with the SEC by DowDuPont and to the
extent incorporated by reference into the Registration Statement, by Dow
and DuPont. While the list of factors presented here is, and the list of
factors presented in the Registration Statement are, considered
representative, no such list should be considered to be a complete
statement of all potential risks and uncertainties. Unlisted factors may
present significant additional obstacles to the realization of
forward-looking statements. Consequences of material differences in
results as compared with those anticipated in the forward-looking
statements could include, among other things, business disruption,
operational problems, financial loss, legal liability to third parties
and similar risks, any of which could have a material adverse effect on
DowDuPont's, Dow's or DuPont's consolidated financial condition, results
of operations, credit rating or liquidity. None of DowDuPont, Dow or
DuPont assumes any obligation to publicly provide revisions or updates
to any forward-looking statements whether as a result of new
information, future developments or otherwise, should circumstances
change, except as otherwise required by securities and other applicable
laws.

The Dow Diamond, DuPont Oval logo, DuPont™ and all products, unless
otherwise noted, denoted with ™, ℠or ® are trademarks or registered
trademarks of The Dow Chemical Company, E. I. du Pont de Nemours and
Company or their affiliates.

View Comments and Join the Discussion!